Smoking-Related Lung Observations Did Not Isolate THC as the Cause
Lung findings in people who smoked cannabis cannot automatically be attributed to THC alone. A historical chapter recognized that smoke contains multiple plant constituents and combustion products, making component-specific claims more difficult than simply identifying cannabis use.
The chapter assembled different kinds of evidence
Nahas discussed clinical reports of respiratory symptoms, pulmonary-function observations, tissue findings and cell-culture experiments involving smoke. These were different evidence categories, not one uniform controlled trial.
Some reports involved selected heavy hashish users who sought medical attention. Such a clinical series cannot by itself estimate the frequency of the same findings among all users.
Smoke exposure and isolated THC are different interventions
The source distinguished cannabinoids from other material produced or carried during smoking. A finding after smoke exposure does not identify the responsible component without additional experimental comparisons.
Likewise, a culture response to smoke cannot establish the complete course of disease in a person. The biological system, exposure and outcome must remain explicit.
Preserve the source’s attribution limits
The chapter acknowledged that some pulmonary findings could not be causally assigned to a specific cannabis constituent. That qualification should accompany the reported observation.
This historical evidence does not provide a present-day comparison among smoking, vaporization and oral products, nor does it establish that an alternative route is harmless. Its narrower contribution is showing why product, route and component attribution belong in the same analysis.
Related: Separating cannabis exposure and impairment.
Research cited
Gabriel G. Nahas. Marihuana: Toxicity and Tolerance. Historical book chapter, pp. 16–36.
